Pyroptosis Antibody Sampler Pack

Pyroptosis Antibody Sampler Pack

The Pyroptosis Antibody Sampler Pack from Assay Genie brings together 8 rigorously validated antibodies spanning the key nodes of this pathway, supplied in a convenient 20µL trial size. It lets researchers screen an entire signalling axis in a single, cost-effective pack — validated for applications including ELISA, IF/ICC, IHC-P, WB — before committing to full-size vials. Each antibody is also available individually in a full 100µL size.

Pyroptosis is a lytic, inflammatory form of programmed cell death executed by gasdermin-family pore-forming proteins, serving as a potent host-defense mechanism that eliminates infected cells and amplifies inflammation through the release of intracellular danger signals and mature cytokines. The pathway is driven by inflammatory caspases that cleave gasdermins to unleash their membrane-permeabilizing activity. In the canonical pathway, inflammasome assembly, often nucleated by sensors such as NLRP3 together with the adaptor ASC/PYCARD, activates Caspase-1, which cleaves Gasdermin D to release its pore-forming N-terminal domain. This fragment oligomerizes in the plasma membrane to form pores through which the mature proinflammatory cytokine IL-1beta and other mediators are released, while osmotic swelling drives membrane rupture. In the noncanonical pathway, cytosolic bacterial lipopolysaccharide is sensed directly by inflammatory caspases including human Caspase-4, which likewise cleaves Gasdermin D to trigger pyroptosis and secondarily engage the NLRP3 inflammasome. Beyond Gasdermin D, the related effector Gasdermin A/GSDMA forms pores in response to distinct proteolytic cues and contributes to epithelial defense. The terminal step of plasma membrane rupture is actively governed by the membrane protein NINJ1, which oligomerizes to mediate the catastrophic lysis that releases large intracellular alarmins. Pyroptosis is critical for clearing intracellular pathogens, but excessive or dysregulated activity drives sepsis, autoinflammatory syndromes, and tissue damage, and it is increasingly recognized as a determinant of antitumor immunity. Investigating the initiation, execution, and membrane-rupture phases requires reagents spanning caspases, gasdermins, and rupture machinery. This sampler pack brings together validated antibodies against Gasdermin D, Gasdermin A/GSDMA, Caspase-1, Caspase-4, NINJ1, NLRP3, IL-1beta, and ASC/PYCARD for studying pyroptotic cell death and its inflammatory consequences.